Regenerative knee cell therapy for arthritis pain and swelling
Treatments studied
Part of Bones, joints & muscles clinical trials.
This Phase 2 study tests a patient’s own (autologous) regenerative cell treatment to reduce knee pain and inflammation from osteoarthritis. It mainly looks at whether the treatment is safe and whether it can improve symptoms over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have knee osteoarthritis that’s at least “grade 2,” from wear-and-tear or injury
- You’re between 18 and 90 years old
- Your kidney, heart, and lung function (checked by blood tests and assessments) look adequate
- Your blood can clot normally (tests like INR and APTT must be below the study limits)
- You have no immune system problems (no known immunodeficiency)
- You’ve had knee pain for more than 6 months in the target knee
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an “autologous” regenerative cell treatment, meaning cells taken from you, to reduce hip osteoarthritis pain and inflammation. It checks safety first and looks for improvements in how you feel and move.
This trial tests a treatment using your own (autologous) regenerative cells to reduce pain and inflammation from shoulder osteoarthritis. It may help people with long-lasting shoulder pain, but you must meet several health and medication timing requirements.
This trial tests a joint treatment made from your own platelets (platelet-rich plasma, or PRP) combined with other biologic material (from fat tissue and/or bone marrow) to help osteoarthritis symptoms. It may be an option if you have early-to-moderate osteoarthritis in a major joint and meet safety requirements.
This trial tests a regenerative therapy made from a patient’s own fat tissue (a “cellular” treatment) to reduce pain and improve function in arthritis-related problems. It may help people with inflammatory or degenerative arthritis changes, if they meet safety and tissue-donation requirements.
This Phase 4 study tests whether injections made from body material—SVF or PRP—can reduce pain and improve function in people with knee osteoarthritis. You would be randomly assigned to one of the treatment approaches, and your knee would be monitored over the study.
This study tests a potential new treatment for knee osteoarthritis using stem cells from umbilical cord tissue. The therapy is injected into the knee to see if it can reduce pain and improve function, and it's being compared to a placebo.
Hear when a new Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.